|
Abstract
Counterfeiting is rampant in all industries and
pharmaceutical industry is no exception. Counterfeit
drugs are a threat to public health because the
consumers cannot distinguish between the real and the
fake drug. The problem is more pronounced in developing
countries, where there is a shortage of drugs, and the
drug laws are too weak. A counterfeit drug is a
medicine, which is deliberately and fraudulently
mislabelled with respect to identity and/or source.
Counterfeiting can apply to both branded and generic
products and counterfeit products may include products
with the correct ingredients or with the wrong
ingredients, without active ingredients, with
insufficient active ingredients or with fake packaging.
Manufacturing and distributing fake drugs is a big
money-spinning business that is beginning to threaten
the real pharmaceutical industry. The presence of its
menace is felt by each and everyone in the industry;
however, little has been done to curb it. The legal
framework, meant to prevent such crime, is also in
place, but either it is too weak or has too many
loopholes.
For full text of this article contact the publisher on
info@kppub.com
|
The above content is an
abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate,
New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email:
info@kppub.com /
fpc@vsnl.com, Website:
http://www.kppub.com |
